Patents by Inventor Marie Meyer

Marie Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORM OF LNP023
    Publication number: 20250270186
    Abstract: Described herein is a crystalline hydrate form of LNP023 hydrochloride and to a process for its preparation. Furthermore, described herein is a pharmaceutical composition comprising the crystalline hydrate form of LNP023 hydrochloride, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition described herein can be used to treat a disease and disorder mediated by complement activation.
    Type: Application
    Filed: May 13, 2025
    Publication date: August 28, 2025
    Inventors: Zichen JIA, Philipp LUSTENBERGER, Marie MEYER, Massimo MORATTO
  • Crystalline form of LNP023
    Patent number: 12384758
    Abstract: Described herein is a crystalline hydrate form of LNP023 hydrochloride and to a process for its preparation. Furthermore, described herein is a pharmaceutical composition comprising the crystalline hydrate form of LNP023 hydrochloride, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition described herein can be used to treat a disease and disorder mediated by complement activation.
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: August 12, 2025
    Assignee: NOVARTIS AG
    Inventors: Zichen Jia, Philipp Lustenberger, Marie Meyer, Massimo Moratto
  • CRYSTALLINE FORM OF LNP023
    Publication number: 20230265067
    Abstract: Described herein is a crystalline hydrate form of LNP023 hydrochloride and to a process for its preparation. Furthermore, described herein is a pharmaceutical composition comprising the crystalline hydrate form of LNP023 hydrochloride, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition described herein can be used to treat a disease and disorder mediated by complement activation.
    Type: Application
    Filed: February 14, 2023
    Publication date: August 24, 2023
    Inventors: Zichen JIA, Philipp LUSTENBERGER, Marie MEYER, Massimo MORATTO
  • Crystalline form of LNP023
    Patent number: 11603363
    Abstract: Described herein is a crystalline hydrate form of LNP023 hydrochloride and to a process for its preparation. Furthermore, described herein is a pharmaceutical composition comprising the crystalline hydrate form of LNP023 hydrochloride, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition described herein can be used to treat a disease and disorder mediated by complement activation.
    Type: Grant
    Filed: May 17, 2021
    Date of Patent: March 14, 2023
    Assignee: Novartis AG
    Inventors: Zichen Jia, Philipp Lustenberger, Marie Meyer, Massimo Moratto
  • CRYSTALLINE FORM OF LNP023
    Publication number: 20210371394
    Abstract: Described herein is a crystalline hydrate form of LNP023 hydrochloride and to a process for its preparation. Furthermore, described herein is a pharmaceutical composition comprising the crystalline hydrate form of LNP023 hydrochloride, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition described herein can be used to treat a disease and disorder mediated by complement activation.
    Type: Application
    Filed: May 17, 2021
    Publication date: December 2, 2021
    Inventors: Zichen JIA, Philipp LUSTENBERGER, Marie MEYER, Massimo MORATTO
  • Cartilage treatment probe
    Patent number: 8066700
    Abstract: An electrosurgical instrument includes a shaft, a flexible portion, and a head coupled to the shaft through the flexible portion and pivotably coupled to the flexible portion. The head includes a non-conductive surface and an electrically conductive surface. The flexible portion is configured to bias the non-conductive surface and the electrically conductive surface towards a tissue surface, such as cartilage. The non-conductive surface may include a material having a thermal conductivity less than or equal to about 30 W/m*K and/or a volume resistivity greater than or equal to about 1×1014 ohm*cm. The non-conductive surface may include a ceramic such as Macor® ceramic, ZTA ceramic, and/or 99.5% alumina ceramic.
    Type: Grant
    Filed: November 30, 2004
    Date of Patent: November 29, 2011
    Assignee: Smith & Nephew, Inc.
    Inventors: Kobi Iki, William M. Ambrisco, Douglas M. Lorang, Alan P. Gannon, Richard M. Ranalli, Mathew E. Mitchell, Marie Meyer, Mark Markel, Yan Lu, Ryland B. Edwards, III
  • Cartilage treatment probe
    Publication number: 20050245925
    Abstract: An electrosurgical instrument includes a shaft, a flexible portion, and a head coupled to the shaft through the flexible portion and pivotably coupled to the flexible portion. The head includes a non-conductive surface and an electrically conductive surface. The flexible portion is configured to bias the non-conductive surface and the electrically conductive surface towards a tissue surface, such as cartilage. The non-conductive surface may include a material having a thermal conductivity less than or equal to about 30 W/m*K and/or a volume resistivity greater than or equal to about 1×1014 ohm*cm. The non-conductive surface may include a ceramic such as Macor® ceramic, ZTA ceramic, and/or 99.5% alumina ceramic.
    Type: Application
    Filed: November 30, 2004
    Publication date: November 3, 2005
    Inventors: Kobi Iki, William Ambrisco, Douglas Lorang, Alan Gannon, Richard Ranalli, Mathew Mitchell, Marie Meyer, Mark Markel, Yan Lu, Ryland Edwards